July 8 (Reuters) - Ensysce Biosciences Inc ENSC.O :
* ENSYSCE BIOSCIENCES RECEIVES NOTICE OF AWARD FOR YEAR
THREE OF
MULTI-YEAR NIDA GRANT FOR THE CLINICAL DEVELOPMENT OF ITS NEXT
GENERATION OPIOID PRODUCTS WITH OVERDOSE PROTECTION
* ENSYSCE BIOSCIENCES INC - AN ADDITIONAL $2.8 MILLION AWARD
FOR
YEAR FOUR IS PENDING.
* ENSYSCE BIOSCIENCES INC - AWARD WILL PROVIDE $2.8 MILLION
TO
INITIATE A PHASE 1 STUDY OF FIRST MPAR OVERDOSE PROTECTION
PRODUCT IN U.S., PF614-MPAR
Source text for Eikon: ID:nGNX1HB7SL
Further company coverage: ENSC.O
((Reuters.Briefs@thomsonreuters.com;))